Lifestyle or pharmacotherapy in cardio-metabolic disease prevention
Cardio-metabolic diseases are the leading causes of premature death worldwide. The conditions are together some of the most prevalent and severe multimorbidities and include conditions such as diabetes, hypertension, coronary heart disease and stroke. People with these conditions are at a higher ris...
Main Authors: | Borenyi S. Seidu, Hanad Osman, Samuel Seidu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-06-01
|
Series: | Therapeutic Advances in Cardiovascular Disease |
Online Access: | https://doi.org/10.1177/17539447231177175 |
Similar Items
-
An Innovative Chemical Adherence Test Demonstrates Very High Rates of Nonadherence to Oral Cardio-Metabolic Medications
by: Hanad Osman, et al.
Published: (2023-12-01) -
Managing vascular risk factors among obese quitters with diabetes: how intensive lifestyle intervention and novel pharmacotherapy can work in concert
by: Kar, D, et al.
Published: (2017) -
Prediabetes: lifestyle, pharmacotherapy or regulation?
by: Jonathan E. Shaw
Published: (2019-07-01) -
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy
by: M V Maevskaya, et al.
Published: (2019-02-01) -
Ketogenic Diets and Cardio-Metabolic Diseases
by: Weiyue Zhang, et al.
Published: (2021-11-01)